News, Policy & Media

05Nov

Helen Tucker announced as BIVDA's Chair Elect

BIVDA is delighted to announce that Helen Tucker, BIVDA board member and Managed Services Contracts Manager at Thermo Fisher Scientific, has been confirmed as our Chair-Elect, and will take over from current Chair Darren Stenlake from Sysmex in Spring 2022.

 

Commenting on her appointment, Helen said;

"There is no doubt that BIVDA is a leading voice for the diagnostics industry and is at the forefront of driving external stakeholder engagement. I believe that, as members of BIVDA, we all have a role to play in driving the message on innovation and the adoption new technologies, to support better healthcare outcomes. I have learnt a lot from my engagement with BIVDA about the broader diagnostics industry and am keen to continue in my role, to help develop and drive the BIVDA message both internally with our membership, but more importantly with our external stakeholders."

 

BIVDA Chief Executive Doris-Ann Williams said;

"Helen has been an active member of the BIVDA Executive Board and I am delighted that she has become Chair Elect. It is also vital for BIVDA to have continuity and establishing a Chair Elect in advance means that all the leadership from our current Chair, Darren Stenlake, can be continued and built upon."

 

BIVDA Chair Darren Stenlake said:

"While it may seem early to bring in a chair elect I feel this a key responsibility of the board to ensure business continuity and further to allow for a clearer and more fluid transition between chairs with continued focus on the BIVDA strategy.

It is a pleasure working with Helen, she is an incredibly valuable member of the board in driving the changes needed within BIVDA to develop and enhance the support we offer our members. Helen is passionate about diagnostics and with regard BIVDA about enhancing the our position as the association of choice for the IVD industry. She will serve our members well."

Related

Thousands of participants across Greater Manchester area are donating blood samples to this trial of...

Read More >

The Government has announced the opening of the ‘Future Fund: Breakthrough’ funding prog...

Read More >

£149m has been allocated by Government to support increased rapid coronavirus testing in care ...

Read More >

A webinar was held on 6 July 2022 on how diagnostics companies should respond to new NHS systems and...

Read More >

Health Secretary Matt Hancock has set out the priority groups for testing as the Government’s ...

Read More >

BIVDA has launched the latest in its series of strategic papers, ‘The Digital Revolution&rsquo...

Read More >